

AMCP eModel is the ultimate tool for communication of health economic models and value evidence. Find out more about this tech partnership and this health economic modeling platform to support the exchange of clinical and economic information between manufacturers and payers.

AMCP partners with FormularyDecisions to enhance information sharing and formulary decision-making by creating a platform for current, credible, and compliant information exchange between life science companies and active, qualified healthcare decision-makers.
Featured









-
Health Information Technology Resources
-
Digital Therapeutics Resources
-
Health Disparities Resources
-
Value-Based Contracts Resources
Meetings Proceedings & Findings
View More


Latest News & Resources
Sponsored webinar that reviewed clinical and population measures for asthma control, guideline recommendations for management, and studies that show improved control using different methods.
Sponsored webinar that introduced a new treatment for chronic graft-versus-host disease (cGVHD).

Sponsored webinar that introduced a new treatment for chronic graft-versus-host disease (cGVHD).
Sponsored webinar that reviewed Severe Eosinophilic Asthma (SEA).
Sponsored webinar that provided an overview of trial data related to the development of a blood-based multi-cancer early detection test.
Sponsored webinar that provided an overview of trial data related to the development of a blood-based multi-cancer early detection test.
From the AMCP Policy Digest, AMCP's policies regarding dispensing issues.
Sponsored webinar that discussed the urgency needed to diagnose lupus nephritis as early as possible, and the multidisciplinary care needed in patient management to prevent irreversible kidney damage and progression to end-stage renal disease (ESRD).
Sponsored webinar that discussed the urgency needed to diagnose lupus nephritis as early as possible, and the multidisciplinary care needed in patient management to prevent irreversible kidney damage and progression to end-stage renal disease (ESRD).

AMCP supports regulatory and legislative provisions relating to opioid management that ensure appropriate patient access and treatment of uncontrolled pain, while limiting abuse and diversion of opioids and opioid potentiators. .
Sponsored webinar that provided insights into the "hidden" burden of Systemic Lupus Erythematosus (SLE): a multisystemic autoimmune disease.
From the AMCP Policy Digest, AMCP's policies regarding drug pricing.